UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 121

Sortiert nach

Expectations and outcomes of varying treatment strategies for CML presenting during pregnancy

British journal of haematology, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

P714: EFFECT OF TYROSINE KINASE INHIBITORS ON MALE FERTILITY IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKAEMIA

HemaSphere, 2022-06, Vol.6, p.609-610

2022

Link zum Volltext

Verfügbarkeit prüfen

P701: COVID‐19 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN TREATMENT‐FREE REMISSION: DISEASE SEVERITY AND IMPACT ON TFR STATUS

HemaSphere, 2022-06, Vol.6, p.596-597

2022

Link zum Volltext

Verfügbarkeit prüfen

P713: REAL‐WORLD MANAGEMENT OF PATIENTS WITH CHRONIC MYELOID LEUKAEMIA (CML): FIRST ANALYSIS FROM THE UK NATIONAL REGISTRY FOR CML

HemaSphere, 2022-06, Vol.6, p.608-609

2022

Link zum Volltext

Verfügbarkeit prüfen

P706: ASCIMINIB USE IN CML: THE UK EXPERIENCE

HemaSphere, 2022-06, Vol.6, p.601-602

2022

Link zum Volltext

Verfügbarkeit prüfen

132 RETROSPECTIVE ANALYSIS OF HIGH-RISK MYELODYSPLASTIC SYNDROME AND SECONDARY ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH ALLOGENEIC TRANSPLANTATION AT SAN RAFFAELE SCIENTIFIC INSTITUTE: A SINGLE CENTER EXPERIENCE

Leukemia research, 2015-04, Vol.39, p.S67-S68

2015

Link zum Volltext

Verfügbarkeit prüfen

PS1442 PROTEASOME INHIBITOR CARFILZOMIB HAS SYNTHETIC LETHALITY WITH RUXOLITINIB IN MYELOPROLIFERATIVE NEOPLASMS

HemaSphere, 2019-06, Vol.3 (S1), p.664-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

PS1194 AGE ≥59 YEARS IS ASSOCIATED WITH A HIGHER PROBABILITY OF CARDIOVASCULAR EVENTS IN PATIENTS RECEIVING NILOTINIB FOR CML: A SINGLE CENTRE RETROSPECTIVE ANALYSIS

HemaSphere, 2019-06, Vol.3 (S1), p.544-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Is COVID‐19 less severe in CML patients than in those with other haematological cancers?

British journal of haematology, 2022-02, Vol.196 (3), p.471-472

Claudiani, Simone

2022

Link zum Volltext

Verfügbarkeit prüfen

Prolonged treatment-free remission in chronic myeloid leukemia patients with previous BCR-ABL1 kinase domain mutations

Haematologica (Roma), 2020-05, Vol.105 (5), p.e225

2020

Link zum Volltext

Verfügbarkeit prüfen

The argument for using imatinib in CML

Hematology, 2018-11, Vol.2018 (1), p.161-167

2018

Link zum Volltext

Verfügbarkeit prüfen

Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies

Nature communications, 2022-11, Vol.13 (1), p.6922-6922, Article 6922

2022

Link zum Volltext

Verfügbarkeit prüfen

E14a2 BCR-ABL1 transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy

Haematologica (Roma), 2017-08, Vol.102 (8), p.e297

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance

Leukemia, 2024-04, Vol.38 (4), p.796-802

2024

Link zum Volltext

Verfügbarkeit prüfen

Spastin subcellular localization is regulated through usage of different translation start sites and active export from the nucleus

Experimental cell research, 2005-10, Vol.309 (2), p.358-369

2005

Link zum Volltext

Verfügbarkeit prüfen

Similar therapeutic efficacy between a single administration of gene therapy and multiple administrations of recombinant enzyme in a mouse model of lysosomal storage disease

Human gene therapy, 2014-07, Vol.25 (7), p.609

2014

Link zum Volltext

Verfügbarkeit prüfen

The influence of salivary amylase on total amylase elevation in CML patients treated with TKI therapy: a case series of 3 patients

Leukemia & lymphoma, 2019-11, Vol.60 (13), p.3333-3334

2019

Link zum Volltext

Verfügbarkeit prüfen

Cross-talk between androgen receptor/filamin A and TrkA regulates neurite outgrowth in PC12 cells

Molecular biology of the cell, 2015-08, Vol.26 (15), p.2858-2872

2015

Link zum Volltext

Verfügbarkeit prüfen

Durable humoral responses after the second anti‐SARS‐CoV‐2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors

British journal of haematology, 2022-04, Vol.197 (1), p.e1-e4

2022

Link zum Volltext

Verfügbarkeit prüfen

TKI dose reduction can effectively maintain major molecular remission in patients with chronic myeloid leukaemia

British journal of haematology, 2021-04, Vol.193 (2), p.346-355

2021

Link zum Volltext

Verfügbarkeit prüfen

The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia

Bone marrow transplantation (Basingstoke), 2023-07, Vol.58 (7), p.826-828

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia

Leukemia & lymphoma, 2024-04, p.1-6

2024

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Sars-Cov-2 Infection in Patients with Chronic Myeloid Leukemia

Blood, 2020-11, Vol.136 (Supplement 1), p.20-20

2020

Link zum Volltext

Verfügbarkeit prüfen

FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions

BMC medical genomics, 2023-07, Vol.16 (1), p.172-172, Article 172

2023

Link zum Volltext

Verfügbarkeit prüfen

Assessment of quantitative polymerase chain reaction for BCR–ABL1 transcripts in chronic myeloid leukaemia: Are improved outcomes in patients with e14a2 transcripts an artefact of technology?

British journal of haematology, 2022-04, Vol.197 (1), p.52-62

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(118)
Berichte
(3)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(63)
Science & Technology
(52)
Life Sciences & Biomedicine
(51)
Male
(32)
Female
(28)
Middle Aged
(26)
Hematology
(24)
Adult
(19)
Radionuclide Imaging
(18)
Aged
(17)
Oncology
(17)
Biological And Medical Sciences
(14)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(14)
Medical Sciences
(13)
Leukemia
(11)
Child
(10)
Adolescent
(9)
Child, Preschool
(9)
Chronic Myeloid Leukemia
(9)
Patients
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Expectations and outcomes of varying treatment strategies for CML presenting during pregnancy

P714: EFFECT OF TYROSINE KINASE INHIBITORS ON MALE FERTILITY IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKAEMIA

P701: COVID‐19 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN TREATMENT‐FREE REMISSION: DISEASE SEVERITY AND IMPACT ON TFR STATUS

P713: REAL‐WORLD MANAGEMENT OF PATIENTS WITH CHRONIC MYELOID LEUKAEMIA (CML): FIRST ANALYSIS FROM THE UK NATIONAL REGISTRY FOR CML

P706: ASCIMINIB USE IN CML: THE UK EXPERIENCE

132 RETROSPECTIVE ANALYSIS OF HIGH-RISK MYELODYSPLASTIC SYNDROME AND SECONDARY ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH ALLOGENEIC TRANSPLANTATION AT SAN RAFFAELE SCIENTIFIC INSTITUTE: A SINGLE CENTER EXPERIENCE

PS1442 PROTEASOME INHIBITOR CARFILZOMIB HAS SYNTHETIC LETHALITY WITH RUXOLITINIB IN MYELOPROLIFERATIVE NEOPLASMS

PS1194 AGE ≥59 YEARS IS ASSOCIATED WITH A HIGHER PROBABILITY OF CARDIOVASCULAR EVENTS IN PATIENTS RECEIVING NILOTINIB FOR CML: A SINGLE CENTRE RETROSPECTIVE ANALYSIS

Is COVID‐19 less severe in CML patients than in those with other haematological cancers?

Prolonged treatment-free remission in chronic myeloid leukemia patients with previous BCR-ABL1 kinase domain mutations

The argument for using imatinib in CML

Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies

E14a2 BCR-ABL1 transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy

Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance

Spastin subcellular localization is regulated through usage of different translation start sites and active export from the nucleus

Similar therapeutic efficacy between a single administration of gene therapy and multiple administrations of recombinant enzyme in a mouse model of lysosomal storage disease

The influence of salivary amylase on total amylase elevation in CML patients treated with TKI therapy: a case series of 3 patients

Cross-talk between androgen receptor/filamin A and TrkA regulates neurite outgrowth in PC12 cells

Durable humoral responses after the second anti‐SARS‐CoV‐2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors

TKI dose reduction can effectively maintain major molecular remission in patients with chronic myeloid leukaemia

The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia

Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia

Prevalence of Sars-Cov-2 Infection in Patients with Chronic Myeloid Leukemia

FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions

Assessment of quantitative polymerase chain reaction for BCR–ABL1 transcripts in chronic myeloid leukaemia: Are improved outcomes in patients with e14a2 transcripts an artefact of technology?

Suchergebnisse filtern